The serum immunoglobulin G and M responses induced by immunization of mice with teftiperature-sensitive mutant A/10/25 of Pseudomonas aeruginosa were evaluated by enzyme-linked immunosorbent assay. These antibody responses were immunotype specific, and the immunoglobulin G antibody level, although low, was still significant by day 52 after vaccination.
During the last 2 decades Pseudomonas aeruginosa has emerged as an important nosocomial pathogen. P. aeruginosa infection is particularly frequent among patients with bums, cystic fibrosis, and intravenous drug addictions and in those undergoing immunosuppressive therapy (1) . The likelihood of recovery from P. aeruginosa infection is related to the severity of the patient's underlying disease and, to a certain extent, the capability of the host to mount an immune response against the microorganism. Our laboratory is currently engaged in a project to develop a live P. aeruginosa vaccine, using temperature-sensitive (ts) mutants (8) . Previous work has demonstrated that vaccination of mice with P. aeruginosa strain A/10/25 (which contains one ts mutation) induced immunity to wild-type challenge (8, 12) . The present work was aimed at the evaluation of immunoglobulin G (IgG) and IgM responses of mice to immunization with ts mutant A/10/25. To accomplish this, we developed a micro-enzymelinked immunosorbent assay (ELISA) to quantitate serum antibodies directed against surface antigens and against a purified polysaccharide (PPS) (11) with saline, and the cells were finally suspended to the appropriate density. The antigens for the microplate wells were prepared by culturing P. aeruginosa immunotypes 1, 4, and 5 of Fisher-Devlin-Gnabasik in Trypticase soy broth at 37°C and 300 rpm to an optical density equivalent to 109 CFU/ml. Gentamicin sulfate (Garamycin; Schering Corp., Kenilworth, N.J.) was then added to a concentration of 2,000 jg/ml and the culture was incubated for 120 min. Without washing the cells, 500 jig (final concentration) of carbenicillin disodium salt (Sigma Chemical Co., St. Louis, Mo.) per ml was added to the culture and incubated for another 120 min at 37°C and 300 rpm. Cells were washed three times and suspended to a density equivalent to 1010 CFU/ml in phosphate-buffered saline (pH 7.4) containing 0.02% sodium azide. Samples of the stock suspension were stored at 4°C. Less than 1 in 109 cells per ml was viable.
High-molecular-weight PPS of P. aeruginosa immunotype 1 (Fisher-Devlin-Gnabasik) (kindly provided by Jerald C. Sadoff, Walter Reed Army Institute of Research, Washington, D.C. [11] ) was adsorbed to the microwell surface according to a modification of the method originally described by Gray (3) . Briefly, 0.1 ml of 1,000 jig of PPS per ml in distilled water was added to 0.5 ml of 0.01 N NaOH and mixed for 10 s. The mixture was transferred to another tube containing 0.5 mg of cyanuric chloride (Sigma) and mixed vigorously for 10 s. Then, 0.1 ml of 0.1% poly-L-lysine (Sigma) in distilled water was added to the mixture and incubated for 2 h at 4°C. The solution of PPS coupled to poly-L-lysine was diluted to the appropriate concentration in phosphate-buffered saline and 50 [lI was placed in each well of 96-microwell plates (NUNC Immunoplates I; GIBCO Laboratories, Grand Island, N.Y.). Plates were incubated overnight at 4°C.
Antibiotic-killed P. aeruginosa were adsorbed on the nlicrowells by direct incubation. The stock suspension of bacteria was washed once with phosphate-buffered saline and suspended to an appropriate density in 50 mM sodium carbonate-bicarbonate buffer, pH 9.6. A 50-,ul portion of the bacterial suspension was placed in each microwell and the plates were incubated overnight at 4°C.
Affinity-purified goat anti-mouse IgG and IgM (y-and pi-chain specific, respectively) antibodies conjugated with alkaline phosphatase were purchased from Cappel Laboratories (West Chester, Pa.). Alkaline phosphatase-conjugated affinity-purified anti-mouse IgA (a-chain specific) was pur- 7 and return to base-line levels by day 22 after immunization with 107 CFU (Fig. 1) . The level of IgM antibodies to P. aeruginosa immunotypes 4 and 5 was not significantly different from that of sera from nonimmunized controls (Fig. 1) . The level of IgM antibodies against PPS exhibited a pattern similar to that detected against P. aeruginosa immunotype 1 density values slightly increased (P < 0.05 at the peak) when compared with those of mice injected with the lower dose.
Intraperitoneal injection of 107 CFU of A/10/25 induced a peak of IgG activity against P. aeruginosa immunotype 1 by day 22. The IgG antibody activity was specific for immunotype 1 (Fig. 2) , similar to that seen with IgM. The IgG reaction with PPS correlated with that against P. aeruginosa immunotype 1. The level of IgG antibodies against both antigens by day 52 after inoculation, although low, was still significantly higher than controls (P < 0.05). (10) . These antibodies, however, do not protect mice challenged with immunotype 4. Our results are in agreement with these findings since, as determined by micro-ELISA, there was no cross-reactivity between immunotypes 1 and 4 or 1 and 5. Heterologous antibodies, as well as IgA antibodies, may have been present in serum samples at concentrations which fell below the sensitivity levels of the micro-ELISA.
In conclusion, we have shown that immunization with ts mutant A/10/25 elicited humoral immune responses with antibodies directed mainly to the immunotype specificity. These responses can be determined by micro-ELISA, using either killed whole-cell preparations of P. aeruginosa or a PPS derived from the slime secreted by P. aeruginosa of the same immunotype.
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